A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab

Recently, the efficacy of immuno-oncologic agents for advanced hepatocellular carcinoma (HCC) has been proven in several trials. In particular, atezolizumab with bevacizumab (AteBeva), as a first-line therapy for advanced HCC, has shown tremendous advances in the IMBrave150 study. However, second or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Jun, Hwang, Sang Youn, Im, Jung Woo, Jeon, Ki Jeong, Jeon, Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202248/
https://www.ncbi.nlm.nih.gov/pubmed/37384023
http://dx.doi.org/10.17998/jlc.2023.02.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202248/
https://www.ncbi.nlm.nih.gov/pubmed/37384023
http://dx.doi.org/10.17998/jlc.2023.02.23

Ejemplares similares